Richard G E Haylock1, Michael Gillies2, Nezahat Hunter2, Wei Zhang2, Mary Phillipson2. 1. Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxfordshire, OX11 0RQ, UK. Richard.Haylock@phe.gov.uk. 2. Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxfordshire, OX11 0RQ, UK.
Abstract
BACKGROUND: This study provides direct evidence of cancer risk from low dose and dose rate occupational external radiation exposures. METHODS: Cancer mortality and incidence were studied in relation to external radiation exposure in the National Registry for Radiation Workers. A cohort of 167,003 workers followed for an average of 32 years was analysed using Poisson regression methods. RESULTS: Mortality and incidence risks were significantly raised for the group of all malignant neoplasms excluding leukaemia (ERR/Sv mortality = 0.28; 90%CI: 0.06, 0.53, ERR/Sv incidence = 0.28; 90%CI: 0.10, 0.48) but with narrower confidence bounds compared with the previous analysis of this cohort reflecting the increased statistical power from the additional 10 years of follow-up information. The linear trends in relative risk for both mortality and incidence of these cancers remained statistically significantly raised when information relating to cumulative doses above 100 mSv was excluded (ERR/Sv mortality = 1.42; 90%CI: 0.51, 2.38 and ERR/Sv incidence = 1.18; 90%CI: 0.47, 1.92). CONCLUSIONS: This study improved the precision of the cancer risk estimates seen in the third analysis of the NRRW cohort. The overall results remain consistent with the risk estimates from the Life Span Study and those adopted in the current ICRP recommendations.
BACKGROUND: This study provides direct evidence of cancer risk from low dose and dose rate occupational external radiation exposures. METHODS:Cancer mortality and incidence were studied in relation to external radiation exposure in the National Registry for Radiation Workers. A cohort of 167,003 workers followed for an average of 32 years was analysed using Poisson regression methods. RESULTS: Mortality and incidence risks were significantly raised for the group of all malignant neoplasms excluding leukaemia (ERR/Sv mortality = 0.28; 90%CI: 0.06, 0.53, ERR/Sv incidence = 0.28; 90%CI: 0.10, 0.48) but with narrower confidence bounds compared with the previous analysis of this cohort reflecting the increased statistical power from the additional 10 years of follow-up information. The linear trends in relative risk for both mortality and incidence of these cancers remained statistically significantly raised when information relating to cumulative doses above 100 mSv was excluded (ERR/Sv mortality = 1.42; 90%CI: 0.51, 2.38 and ERR/Sv incidence = 1.18; 90%CI: 0.47, 1.92). CONCLUSIONS: This study improved the precision of the cancer risk estimates seen in the third analysis of the NRRW cohort. The overall results remain consistent with the risk estimates from the Life Span Study and those adopted in the current ICRP recommendations.
Authors: Natalia Gudzenko; Kiyohiko Mabuchi; Alina V Brenner; Mark P Little; Maureen Hatch; Vladimir Drozdovitch; Vibha Vij; Vadim Chumak; Elena Bakhanova; Natalia Trotsyuk; Victor Kryuchkov; Ivan Golovanov; Dimitry Bazyka; Elizabeth K Cahoon Journal: Eur J Epidemiol Date: 2021-12-12 Impact factor: 8.082
Authors: Keith Siau; George Webster; Mark Wright; Ben Maher; Brian Stedman; Gavin Johnson; Saqib Ahmad; Nadeem Tehami Journal: Frontline Gastroenterol Date: 2020-12-11
Authors: Kiyohiko Mabuchi; Dale L Preston; Alina V Brenner; Hiromi Sugiyama; Mai Utada; Ritsu Sakata; Atsuko Sadakane; Eric J Grant; Benjamin French; Elizabeth K Cahoon; Kotaro Ozasa Journal: Radiat Res Date: 2021-01-01 Impact factor: 2.841
Authors: Klervi Leuraud; David B Richardson; Elisabeth Cardis; Robert D Daniels; Michael Gillies; Richard Haylock; Monika Moissonnier; Mary K Schubauer-Berigan; Isabelle Thierry-Chef; Ausrele Kesminiene; Dominique Laurier Journal: Radiat Environ Biophys Date: 2021-01-21 Impact factor: 2.017